Key clinical point: Sickle cell disease patients appear to be at lower risk for opioid-related mortality than the general U.S. population.
Major finding: While the rate of inpatient death from opioid overdose rose 350% among the general U.S. population from 1998 to 2013, it remained essentially at zero among patients with sickle cell disease.
Study details: A retrospective analysis of discharge diagnoses from the National Inpatient Sample from 1998 to 2013.
Disclosures: The researchers reported having no relevant financial disclosures.
Akinboro OA et al. ASH 2018, Abstract 315.